U.S. flag

An official website of the United States government, Department of Justice.

Prescription Drug Monitoring Program: Nevada State Profile (2021)

NCJ Number
Date Published
13 pages

The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Nevada state Prescription Drug Monitoring Program (PDMP).



The name of the Nevada PDMP is the Prescription Controlled Substance Abuse Prevention Task Force PDMP region: West. The administrative agency is the Nevada Board of Pharmacy. The email address is provided, along with the URLs of the PDMP website and related websites for enrollment, query, and data upload. Contact information is provided for the Program Administrator and the Executive Secretary. For 2020, the state population was 3,108,462, and there were 14,388 DEA-registered prescribers and 490 DEA-registered dispensers. A total of 25 types of reports are available from the PDMP. Funding for the PDMP comes from licensing fees and a BJA grant. The amount of the 2021 budget is not reported. Three staff members and one part-time employee perform operational tasks, and one employee is responsible for technical operations. Three employees perform analytical/epidemiological tasks. Key dates in the establishment and development of the PDMP are provided, along with access information for statutes and rules pertinent to the establishment and procedures of the PDMP. The PDMP maintains active data in a retrievable form for 5 years. User training is available for prescribers, dispensers, law enforcement personnel, and the Regulatory Board. Training is required before PDMP use only for prescribers and dispensers. Law enforcement use requires a subpoena or court order/approval. Enrollment is required for prescribers and dispensers. Only prescribers are required to use the PDMP. Although a veterinary icon is required on PDMP reports when one is involved in substance prescribing, veterinarians are not permitted to access the PDMP, and they are exempted from enrollment. Substances monitored include those listed in Schedules II-V.

Date Published: January 1, 2021